R. Ravasio, F. Rigo, E. Lattuada, E. Concia, and M. Lanzafame, “The cost of a combination Anti-Retroviral Therapy (cART) optimization pathway as maintenance therapy in HIV-1 infected patients”, FE, vol. 18, no. 1, Nov. 2017.